Park Ji Eun, Wu Ying, Carmony Kimberly Cornish, Miller Zachary, Sharma Lalit Kumar, Lee Do-Min, Kim Doo-Young, Lee Wooin, Kim Kyung-Bo
Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA 40536-0596.
Mol Biosyst. 2014 Feb;10(2):196-200. doi: 10.1039/c3mb70471h.
Mammalian cells have two main types of proteasomes, the constitutive proteasome and the immunoproteasome, each containing a distinct set of three catalytic subunits. Recently, additional proteasome subtypes containing a non-standard mixture of catalytic subunits have gained increasing attention, especially due to their presence in cancer settings. However, practical methods for identifying proteasome subtypes have been lacking. Here, we report the development of the first fluorescence resonance energy transfer (FRET)-based strategy that can be utilized to identify different proteasome subtypes present within cells. We have developed FRET donor- and acceptor-probes that are based on previously reported peptide epoxyketones and selectively target individual proteasome catalytic subunits. Using the purified proteasome and cancer cell lysates, we demonstrate the feasibility of a FRET-based approach for determining the catalytic subunit composition of individual 20S proteasome subtypes. Ultimately, this approach may be utilized to study the functions of individual proteasome subtypes in cells.
哺乳动物细胞有两种主要类型的蛋白酶体,即组成型蛋白酶体和免疫蛋白酶体,每种都包含一组不同的三个催化亚基。最近,含有非标准催化亚基混合物的其他蛋白酶体亚型受到越来越多的关注,特别是因为它们存在于癌症环境中。然而,一直缺乏鉴定蛋白酶体亚型的实用方法。在这里,我们报告了第一种基于荧光共振能量转移(FRET)的策略的开发,该策略可用于识别细胞内存在的不同蛋白酶体亚型。我们开发了基于先前报道的肽环氧酮的FRET供体和受体探针,并选择性地靶向单个蛋白酶体催化亚基。使用纯化的蛋白酶体和癌细胞裂解物,我们证明了基于FRET的方法用于确定单个20S蛋白酶体亚型的催化亚基组成的可行性。最终,这种方法可用于研究细胞中单个蛋白酶体亚型的功能。